NYSE - Delayed Quote USD

Labcorp Holdings Inc. (LH)

250.94
+5.21
+(2.12%)
At close: May 12 at 4:00:02 PM EDT
250.94
0.00
(0.00%)
After hours: May 12 at 6:01:08 PM EDT

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Adam H. Schechter President, CEO & Chairman 4.15M -- 1965
Ms. Julia A. Wang CFO & Executive VP 669.36k -- 1972
Mr. Mark S. Schroeder Executive VP, President of Diagnostics Laboratories & COO 1.46M 214.78k 1961
Dr. Brian J. Caveney J.D., M.D., M.P.H. EVP, President of Early Development Research Laboratories and Chief Medical & Scientific Officer 1.29M -- 1974
Ms. Anita Z. Graham Executive VP & Chief Human Resources Officer 1.58M -- 1971
Mr. Peter J. Wilkinson Senior VP & Chief Accounting Officer -- -- 1971
Mr. Akinbolade Oyegunwa M.B.A., Ph.D. Executive VP and Chief Information & Technology Officer -- -- 1983
Christin O'Donnell Vice President of Investor Relations -- -- --
Ms. Sandra D. van der Vaart J.D. Executive VP, Chief Legal Officer & Corporate Secretary -- -- 1960
Ms. Amy B. Summy EVP, Chief Marketing Officer & Consumer Business Lead -- -- 1966

Labcorp Holdings Inc.

358 South Main Street
Burlington, NC 27215
United States
336 229 1127 https://www.labcorp.com
Sector: 
Healthcare
Full Time Employees: 
60,900

Description

Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid, PAP, hemoglobin A1C, prostate-specific antigens, sexually transmitted diseases, hepatitis C, vitamin D, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs). In addition, the company offers online and mobile applications that enable patients to check offerings, schedule PSC visits, check-in upon PSC arrival, complete documentation, access tests and test results, and manage their accounts; online applications for providers, MCOs, and accountable care organizations; specimen collection services; and drug development, medical device, and companion diagnostic development solutions, as well as support for crop protection and chemical testing. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; and MCOs, employer plans, other health insurance providers, governments, physician, large provider organizations, other healthcare providers, hospitals and health systems, patients and consumers, crop protection and chemical companies, academic institutions, independent clinical laboratories, and retailers. The company was founded in 1995 is headquartered in Burlington, North Carolina.

Corporate Governance

Labcorp Holdings Inc.’s ISS Governance QualityScore as of May 1, 2025 is 2. The pillar scores are Audit: 4; Board: 7; Shareholder Rights: 1; Compensation: 3.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

May 29, 2025 at 12:00 AM UTC

Ex-Dividend Date

June 11, 2025 at 12:00 AM UTC

Dividend Date

July 30, 2025 at 10:50 AM UTC - August 3, 2025 at 10:50 AM UTC

Labcorp Holdings Inc. Earnings Date

Recent Events

May 8, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

April 29, 2025 at 12:00 AM UTC

10-Q: Periodic Financial Reports

April 10, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

April 4, 2025 at 12:00 AM UTC

DEFA14A: Proxy Statements

March 31, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

February 25, 2025 at 12:00 AM UTC

10-K: Periodic Financial Reports

February 6, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

January 31, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

January 10, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

January 8, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

Related Tickers